BRIEF

on SINGULUS TECHNOLOGIES AG (isin : DE0007238909)

SINGULUS TECHNOLOGIES Advances in Contact Lens Production with MEDLINE System

Stock price chart of SINGULUS TECHNOLOGIES AG (EBR:SNG) showing fluctuations.

SINGULUS TECHNOLOGIES AG announced progress in the adoption of its MEDLINE production system for contact lenses. This system, developed for enhancing the processing of contact lenses, has shown significant advancements in terms of capacity and application range.

The company reported successful recent customer collaborations that helped optimize the machine technology for contact lens production and development, adhering to stringent GxP/FDA and GMP standards. Enhanced procedures tailored to client-specific needs have led to the development of systems capable of processing various types of lenses, including daily and monthly disposables.

Dr. Stefan Rinck, CEO, highlighted the receipt of a new order for the MEDLINE system, showcasing the market's acknowledgment of the system's alignment with industry needs. SINGULUS TECHNOLOGIES sees potential for further engagement in the growing contact lens market thanks to continuous innovations and a rising demand among consumers.

With a focus on sustainable and responsible business practices, the company remains committed to providing state-of-the-art technology in thin-film coating and surface treatment while maintaining environmental consciousness.

R. H.

Copyright © 2024 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all SINGULUS TECHNOLOGIES AG news